O'Shares Investment Advisers’s Bristol-Myers Squibb BMY Stock Holding History

O'Shares Investment Advisers’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-35,510	Closed	-$2.09M	–	268
2020 Q2	$2.09M	Sell	35,510 -69,238	-66%	-$4.14M	0.26%	96
2020 Q1	$5.84M	Sell	104,748 -82	-0.1%	-$5.01K	1.04%	25
2019 Q4	$6.73M	Buy	104,830 +6,870	+7%	+$393K	0.92%	28
2019 Q3	$4.97M	Buy	97,960 +13,279	+16%	+$624K	0.75%	34
2019 Q2	$3.84M	Buy	84,681 +4,947	+6%	+$230K	0.61%	39
2019 Q1	$3.8M	Buy	79,734 +2,328	+3%	+$116K	0.65%	37
2018 Q4	$4.02M	Buy	+77,406	New	+$4.16M	0.77%	31

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

O'Shares Investment Advisers's BMY Position: Q3 2020 in Review

O'Shares Investment Advisers sold out of Bristol-Myers Squibb (BMY) in Q3 2020, closing a stake of 35,510 shares — an estimated $2.09M sold.

O'Shares Investment Advisers first reported a position in BMY in Q4 2018 and held it in 7 quarters. The position peaked at $6.73M in Q4 2019. 2,215 funds tracked by Wall St. Rank hold BMY as of Q3 2020.

O'Shares Investment Advisers reported no remaining Bristol-Myers Squibb position as of Q3 2020 after selling out during the quarter.
O'Shares Investment Advisers sold 35,510 Bristol-Myers Squibb shares in Q3 2020, an estimated $2.09M.
O'Shares Investment Advisers first reported a position in Bristol-Myers Squibb in Q4 2018 and held it in 7 quarters.
O'Shares Investment Advisers's Bristol-Myers Squibb position peaked at $6.73M in Q4 2019.
2,215 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2020.

Based on O'Shares Investment Advisers's 13F filing for Q3 2020, filed 12 Nov 2020.